Global Nucleic Acids For Molecular Diagnosis Market Research Report 2026(Status and Outlook)

December 2025 | 154 pages | ID: NFEE30C9AED4EN
Bosson Research

Abstracts

Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.

The global Nucleic Acids For Molecular Diagnosis market size was estimated at USD 2850.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Nucleic Acids For Molecular Diagnosis market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Nucleic Acids For Molecular Diagnosis market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nucleic Acids For Molecular Diagnosis market.

Global Nucleic Acids For Molecular Diagnosis Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company
Danaher Corporation
Merck KGaA
Eurofins Scientific SE
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Kaneka Eurogentec S.A.
Aji Bio-Pharma
L.G.C Biosearch Technologies
Integrated DNA Technologies
Bio-synthesis Inc.
metabion
QIAGEN
Hongene
Synthgene

Market Segmentation (by Type)

DNA Series
RNA Series

Market Segmentation (by Application)

Infectious Diseases
Early Cancer Screening
Blood Screening
Genetic Diseases
Genome Sequencing
Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Nucleic Acids For Molecular Diagnosis Market

Overview of the regional outlook of the Nucleic Acids For Molecular Diagnosis Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acids For Molecular Diagnosis Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Nucleic Acids For Molecular Diagnosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Nucleic Acids For Molecular Diagnosis
1.2 Key Market Segments
  1.2.1 Nucleic Acids For Molecular Diagnosis Segment by Type
  1.2.2 Nucleic Acids For Molecular Diagnosis Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Nucleic Acids For Molecular Diagnosis Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Nucleic Acids For Molecular Diagnosis Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Nucleic Acids For Molecular Diagnosis Product Life Cycle
3.3 Global Nucleic Acids For Molecular Diagnosis Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acids For Molecular Diagnosis Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acids For Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acids For Molecular Diagnosis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nucleic Acids For Molecular Diagnosis Market Competitive Situation and Trends
  3.8.1 Nucleic Acids For Molecular Diagnosis Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Nucleic Acids For Molecular Diagnosis Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS INDUSTRY CHAIN ANALYSIS

4.1 Nucleic Acids For Molecular Diagnosis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acids For Molecular Diagnosis Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Nucleic Acids For Molecular Diagnosis Market
5.7 ESG Ratings of Leading Companies

6 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Type (2020-2025)
6.3 Global Nucleic Acids For Molecular Diagnosis Market Size by Type (2020-2025)
6.4 Global Nucleic Acids For Molecular Diagnosis Price by Type (2020-2025)

7 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acids For Molecular Diagnosis Market Sales by Application (2020-2025)
7.3 Global Nucleic Acids For Molecular Diagnosis Market Size (M USD) by Application (2020-2025)
7.4 Global Nucleic Acids For Molecular Diagnosis Sales Growth Rate by Application (2020-2025)

8 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET SALES BY REGION

8.1 Global Nucleic Acids For Molecular Diagnosis Sales by Region
  8.1.1 Global Nucleic Acids For Molecular Diagnosis Sales by Region
  8.1.2 Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Region
8.2 Global Nucleic Acids For Molecular Diagnosis Market Size by Region
  8.2.1 Global Nucleic Acids For Molecular Diagnosis Market Size by Region
  8.2.2 Global Nucleic Acids For Molecular Diagnosis Market Size by Region
8.3 North America
  8.3.1 North America Nucleic Acids For Molecular Diagnosis Sales by Country
  8.3.2 North America Nucleic Acids For Molecular Diagnosis Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Nucleic Acids For Molecular Diagnosis Sales by Country
  8.4.2 Europe Nucleic Acids For Molecular Diagnosis Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Nucleic Acids For Molecular Diagnosis Sales by Region
  8.5.2 Asia Pacific Nucleic Acids For Molecular Diagnosis Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Nucleic Acids For Molecular Diagnosis Sales by Country
  8.6.2 South America Nucleic Acids For Molecular Diagnosis Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Nucleic Acids For Molecular Diagnosis Sales by Region
  8.7.2 Middle East and Africa Nucleic Acids For Molecular Diagnosis Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET PRODUCTION BY REGION

9.1 Global Production of Nucleic Acids For Molecular Diagnosis by Region(2020-2025)
9.2 Global Nucleic Acids For Molecular Diagnosis Revenue Market Share by Region (2020-2025)
9.3 Global Nucleic Acids For Molecular Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nucleic Acids For Molecular Diagnosis Production
  9.4.1 North America Nucleic Acids For Molecular Diagnosis Production Growth Rate (2020-2025)
  9.4.2 North America Nucleic Acids For Molecular Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nucleic Acids For Molecular Diagnosis Production
  9.5.1 Europe Nucleic Acids For Molecular Diagnosis Production Growth Rate (2020-2025)
  9.5.2 Europe Nucleic Acids For Molecular Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nucleic Acids For Molecular Diagnosis Production (2020-2025)
  9.6.1 Japan Nucleic Acids For Molecular Diagnosis Production Growth Rate (2020-2025)
  9.6.2 Japan Nucleic Acids For Molecular Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nucleic Acids For Molecular Diagnosis Production (2020-2025)
  9.7.1 China Nucleic Acids For Molecular Diagnosis Production Growth Rate (2020-2025)
  9.7.2 China Nucleic Acids For Molecular Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Danaher Corporation
  10.1.1 Danaher Corporation Basic Information
  10.1.2 Danaher Corporation Nucleic Acids For Molecular Diagnosis Product Overview
  10.1.3 Danaher Corporation Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.1.4 Danaher Corporation Business Overview
  10.1.5 Danaher Corporation SWOT Analysis
  10.1.6 Danaher Corporation Recent Developments
10.2 Merck KGaA
  10.2.1 Merck KGaA Basic Information
  10.2.2 Merck KGaA Nucleic Acids For Molecular Diagnosis Product Overview
  10.2.3 Merck KGaA Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.2.4 Merck KGaA Business Overview
  10.2.5 Merck KGaA SWOT Analysis
  10.2.6 Merck KGaA Recent Developments
10.3 Eurofins Scientific SE
  10.3.1 Eurofins Scientific SE Basic Information
  10.3.2 Eurofins Scientific SE Nucleic Acids For Molecular Diagnosis Product Overview
  10.3.3 Eurofins Scientific SE Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.3.4 Eurofins Scientific SE Business Overview
  10.3.5 Eurofins Scientific SE SWOT Analysis
  10.3.6 Eurofins Scientific SE Recent Developments
10.4 Thermo Fisher Scientific Inc.
  10.4.1 Thermo Fisher Scientific Inc. Basic Information
  10.4.2 Thermo Fisher Scientific Inc. Nucleic Acids For Molecular Diagnosis Product Overview
  10.4.3 Thermo Fisher Scientific Inc. Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.4.4 Thermo Fisher Scientific Inc. Business Overview
  10.4.5 Thermo Fisher Scientific Inc. Recent Developments
10.5 Agilent Technologies, Inc.
  10.5.1 Agilent Technologies, Inc. Basic Information
  10.5.2 Agilent Technologies, Inc. Nucleic Acids For Molecular Diagnosis Product Overview
  10.5.3 Agilent Technologies, Inc. Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.5.4 Agilent Technologies, Inc. Business Overview
  10.5.5 Agilent Technologies, Inc. Recent Developments
10.6 Kaneka Eurogentec S.A.
  10.6.1 Kaneka Eurogentec S.A. Basic Information
  10.6.2 Kaneka Eurogentec S.A. Nucleic Acids For Molecular Diagnosis Product Overview
  10.6.3 Kaneka Eurogentec S.A. Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.6.4 Kaneka Eurogentec S.A. Business Overview
  10.6.5 Kaneka Eurogentec S.A. Recent Developments
10.7 Aji Bio-Pharma
  10.7.1 Aji Bio-Pharma Basic Information
  10.7.2 Aji Bio-Pharma Nucleic Acids For Molecular Diagnosis Product Overview
  10.7.3 Aji Bio-Pharma Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.7.4 Aji Bio-Pharma Business Overview
  10.7.5 Aji Bio-Pharma Recent Developments
10.8 L.G.C Biosearch Technologies
  10.8.1 L.G.C Biosearch Technologies Basic Information
  10.8.2 L.G.C Biosearch Technologies Nucleic Acids For Molecular Diagnosis Product Overview
  10.8.3 L.G.C Biosearch Technologies Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.8.4 L.G.C Biosearch Technologies Business Overview
  10.8.5 L.G.C Biosearch Technologies Recent Developments
10.9 Integrated DNA Technologies
  10.9.1 Integrated DNA Technologies Basic Information
  10.9.2 Integrated DNA Technologies Nucleic Acids For Molecular Diagnosis Product Overview
  10.9.3 Integrated DNA Technologies Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.9.4 Integrated DNA Technologies Business Overview
  10.9.5 Integrated DNA Technologies Recent Developments
10.10 Bio-synthesis Inc.
  10.10.1 Bio-synthesis Inc. Basic Information
  10.10.2 Bio-synthesis Inc. Nucleic Acids For Molecular Diagnosis Product Overview
  10.10.3 Bio-synthesis Inc. Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.10.4 Bio-synthesis Inc. Business Overview
  10.10.5 Bio-synthesis Inc. Recent Developments
10.11 metabion
  10.11.1 metabion Basic Information
  10.11.2 metabion Nucleic Acids For Molecular Diagnosis Product Overview
  10.11.3 metabion Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.11.4 metabion Business Overview
  10.11.5 metabion Recent Developments
10.12 QIAGEN
  10.12.1 QIAGEN Basic Information
  10.12.2 QIAGEN Nucleic Acids For Molecular Diagnosis Product Overview
  10.12.3 QIAGEN Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.12.4 QIAGEN Business Overview
  10.12.5 QIAGEN Recent Developments
10.13 Hongene
  10.13.1 Hongene Basic Information
  10.13.2 Hongene Nucleic Acids For Molecular Diagnosis Product Overview
  10.13.3 Hongene Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.13.4 Hongene Business Overview
  10.13.5 Hongene Recent Developments
10.14 Synthgene
  10.14.1 Synthgene Basic Information
  10.14.2 Synthgene Nucleic Acids For Molecular Diagnosis Product Overview
  10.14.3 Synthgene Nucleic Acids For Molecular Diagnosis Product Market Performance
  10.14.4 Synthgene Business Overview
  10.14.5 Synthgene Recent Developments

11 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET FORECAST BY REGION

11.1 Global Nucleic Acids For Molecular Diagnosis Market Size Forecast
11.2 Global Nucleic Acids For Molecular Diagnosis Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country
  11.2.3 Asia Pacific Nucleic Acids For Molecular Diagnosis Market Size Forecast by Region
  11.2.4 South America Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Nucleic Acids For Molecular Diagnosis by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Nucleic Acids For Molecular Diagnosis Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Nucleic Acids For Molecular Diagnosis by Type (2026-2035)
  12.1.2 Global Nucleic Acids For Molecular Diagnosis Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Nucleic Acids For Molecular Diagnosis by Type (2026-2035)
12.2 Global Nucleic Acids For Molecular Diagnosis Market Forecast by Application (2026-2035)
  12.2.1 Global Nucleic Acids For Molecular Diagnosis Sales (K Units) Forecast by Application
  12.2.2 Global Nucleic Acids For Molecular Diagnosis Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acids For Molecular Diagnosis Market Size by Type (M USD)
Table 4. Global Nucleic Acids For Molecular Diagnosis Market Size by Application
Table 5. Nucleic Acids For Molecular Diagnosis Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acids For Molecular Diagnosis Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acids For Molecular Diagnosis Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acids For Molecular Diagnosis Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acids For Molecular Diagnosis as of 2025)
Table 11. Global Market Nucleic Acids For Molecular Diagnosis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nucleic Acids For Molecular Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acids For Molecular Diagnosis Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nucleic Acids For Molecular Diagnosis Sales by Type (K Units)
Table 27. Global Nucleic Acids For Molecular Diagnosis Market Size by Type (M USD)
Table 28. Global Nucleic Acids For Molecular Diagnosis Sales (K Units) by Type (2020-2025)
Table 29. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Type (2020-2025)
Table 30. Global Nucleic Acids For Molecular Diagnosis Market Size (M USD) by Type (2020-2025)
Table 31. Global Nucleic Acids For Molecular Diagnosis Market Share by Type (2020-2025)
Table 32. Global Nucleic Acids For Molecular Diagnosis Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nucleic Acids For Molecular Diagnosis Sales (K Units) by Application
Table 34. Global Nucleic Acids For Molecular Diagnosis Market Size by Application
Table 35. Global Nucleic Acids For Molecular Diagnosis Sales by Application (2020-2025) & (K Units)
Table 36. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Application (2020-2025)
Table 37. Global Nucleic Acids For Molecular Diagnosis Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nucleic Acids For Molecular Diagnosis Market Share by Application (2020-2025)
Table 39. Global Nucleic Acids For Molecular Diagnosis Sales Growth Rate by Application (2020-2025)
Table 40. Global Nucleic Acids For Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
Table 41. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Region (2020-2025)
Table 42. Global Nucleic Acids For Molecular Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nucleic Acids For Molecular Diagnosis Market Size by Region (2020-2025)
Table 44. North America Nucleic Acids For Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 45. North America Nucleic Acids For Molecular Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nucleic Acids For Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nucleic Acids For Molecular Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nucleic Acids For Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nucleic Acids For Molecular Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nucleic Acids For Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
Table 51. South America Nucleic Acids For Molecular Diagnosis Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nucleic Acids For Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nucleic Acids For Molecular Diagnosis Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nucleic Acids For Molecular Diagnosis Production (K Units) by Region(2020-2025)
Table 55. Global Nucleic Acids For Molecular Diagnosis Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nucleic Acids For Molecular Diagnosis Revenue Market Share by Region (2020-2025)
Table 57. Global Nucleic Acids For Molecular Diagnosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nucleic Acids For Molecular Diagnosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nucleic Acids For Molecular Diagnosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nucleic Acids For Molecular Diagnosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nucleic Acids For Molecular Diagnosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Danaher Corporation Basic Information
Table 63. Danaher Corporation Nucleic Acids For Molecular Diagnosis Product Overview
Table 64. Danaher Corporation Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Danaher Corporation Business Overview
Table 66. Danaher Corporation SWOT Analysis
Table 67. Danaher Corporation Recent Developments
Table 68. Merck KGaA Basic Information
Table 69. Merck KGaA Nucleic Acids For Molecular Diagnosis Product Overview
Table 70. Merck KGaA Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Merck KGaA Business Overview
Table 72. Merck KGaA SWOT Analysis
Table 73. Merck KGaA Recent Developments
Table 74. Eurofins Scientific SE Basic Information
Table 75. Eurofins Scientific SE Nucleic Acids For Molecular Diagnosis Product Overview
Table 76. Eurofins Scientific SE Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Eurofins Scientific SE Business Overview
Table 78. Eurofins Scientific SE SWOT Analysis
Table 79. Eurofins Scientific SE Recent Developments
Table 80. Thermo Fisher Scientific Inc. Basic Information
Table 81. Thermo Fisher Scientific Inc. Nucleic Acids For Molecular Diagnosis Product Overview
Table 82. Thermo Fisher Scientific Inc. Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Inc. Business Overview
Table 84. Thermo Fisher Scientific Inc. Recent Developments
Table 85. Agilent Technologies, Inc. Basic Information
Table 86. Agilent Technologies, Inc. Nucleic Acids For Molecular Diagnosis Product Overview
Table 87. Agilent Technologies, Inc. Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Agilent Technologies, Inc. Business Overview
Table 89. Agilent Technologies, Inc. Recent Developments
Table 90. Kaneka Eurogentec S.A. Basic Information
Table 91. Kaneka Eurogentec S.A. Nucleic Acids For Molecular Diagnosis Product Overview
Table 92. Kaneka Eurogentec S.A. Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Kaneka Eurogentec S.A. Business Overview
Table 94. Kaneka Eurogentec S.A. Recent Developments
Table 95. Aji Bio-Pharma Basic Information
Table 96. Aji Bio-Pharma Nucleic Acids For Molecular Diagnosis Product Overview
Table 97. Aji Bio-Pharma Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Aji Bio-Pharma Business Overview
Table 99. Aji Bio-Pharma Recent Developments
Table 100. L.G.C Biosearch Technologies Basic Information
Table 101. L.G.C Biosearch Technologies Nucleic Acids For Molecular Diagnosis Product Overview
Table 102. L.G.C Biosearch Technologies Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. L.G.C Biosearch Technologies Business Overview
Table 104. L.G.C Biosearch Technologies Recent Developments
Table 105. Integrated DNA Technologies Basic Information
Table 106. Integrated DNA Technologies Nucleic Acids For Molecular Diagnosis Product Overview
Table 107. Integrated DNA Technologies Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Integrated DNA Technologies Business Overview
Table 109. Integrated DNA Technologies Recent Developments
Table 110. Bio-synthesis Inc. Basic Information
Table 111. Bio-synthesis Inc. Nucleic Acids For Molecular Diagnosis Product Overview
Table 112. Bio-synthesis Inc. Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Bio-synthesis Inc. Business Overview
Table 114. Bio-synthesis Inc. Recent Developments
Table 115. metabion Basic Information
Table 116. metabion Nucleic Acids For Molecular Diagnosis Product Overview
Table 117. metabion Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. metabion Business Overview
Table 119. metabion Recent Developments
Table 120. QIAGEN Basic Information
Table 121. QIAGEN Nucleic Acids For Molecular Diagnosis Product Overview
Table 122. QIAGEN Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. QIAGEN Business Overview
Table 124. QIAGEN Recent Developments
Table 125. Hongene Basic Information
Table 126. Hongene Nucleic Acids For Molecular Diagnosis Product Overview
Table 127. Hongene Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Hongene Business Overview
Table 129. Hongene Recent Developments
Table 130. Synthgene Basic Information
Table 131. Synthgene Nucleic Acids For Molecular Diagnosis Product Overview
Table 132. Synthgene Nucleic Acids For Molecular Diagnosis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Synthgene Business Overview
Table 134. Synthgene Recent Developments
Table 135. Global Nucleic Acids For Molecular Diagnosis Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Nucleic Acids For Molecular Diagnosis Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Nucleic Acids For Molecular Diagnosis Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Nucleic Acids For Molecular Diagnosis Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Nucleic Acids For Molecular Diagnosis Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Nucleic Acids For Molecular Diagnosis Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Nucleic Acids For Molecular Diagnosis Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Nucleic Acids For Molecular Diagnosis Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Nucleic Acids For Molecular Diagnosis Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Nucleic Acids For Molecular Diagnosis Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Nucleic Acids For Molecular Diagnosis Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Nucleic Acids For Molecular Diagnosis Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Nucleic Acids For Molecular Diagnosis Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Nucleic Acids For Molecular Diagnosis Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Nucleic Acids For Molecular Diagnosis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acids For Molecular Diagnosis Market Size (M USD), 2025-2035
Figure 5. Global Nucleic Acids For Molecular Diagnosis Market Size (M USD) (2020-2035)
Figure 6. Global Nucleic Acids For Molecular Diagnosis Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acids For Molecular Diagnosis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acids For Molecular Diagnosis Product Life Cycle
Figure 13. Nucleic Acids For Molecular Diagnosis Sales Share by Manufacturers in 2025
Figure 14. Global Nucleic Acids For Molecular Diagnosis Revenue Share by Manufacturers in 2025
Figure 15. Nucleic Acids For Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nucleic Acids For Molecular Diagnosis Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acids For Molecular Diagnosis Revenue in 2025
Figure 18. Industry Chain Map of Nucleic Acids For Molecular Diagnosis
Figure 19. Global Nucleic Acids For Molecular Diagnosis Market PEST Analysis
Figure 20. Global Nucleic Acids For Molecular Diagnosis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nucleic Acids For Molecular Diagnosis Market Share by Type
Figure 27. Sales Market Share of Nucleic Acids For Molecular Diagnosis by Type (2020-2025)
Figure 28. Sales Market Share of Nucleic Acids For Molecular Diagnosis by Type in 2025
Figure 29. Market Share of Nucleic Acids For Molecular Diagnosis by Type (2020-2025)
Figure 30. Market Share of Nucleic Acids For Molecular Diagnosis by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nucleic Acids For Molecular Diagnosis Market Share by Application
Figure 33. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Application (2020-2025)
Figure 34. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Application in 2025
Figure 35. Global Nucleic Acids For Molecular Diagnosis Market Share by Application (2020-2025)
Figure 36. Global Nucleic Acids For Molecular Diagnosis Market Share by Application in 2025
Figure 37. Global Nucleic Acids For Molecular Diagnosis Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nucleic Acids For Molecular Diagnosis Sales Market Share by Region (2020-2025)
Figure 39. Global Nucleic Acids For Molecular Diagnosis Market Size by Region (2020-2025)
Figure 40. North America Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nucleic Acids For Molecular Diagnosis Sales Market Share by Country in 2024
Figure 43. North America Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nucleic Acids For Molecular Diagnosis Market Size by Country in 2024
Figure 45. U.S. Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nucleic Acids For Molecular Diagnosis Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nucleic Acids For Molecular Diagnosis Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nucleic Acids For Molecular Diagnosis Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nucleic Acids For Molecular Diagnosis Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nucleic Acids For Molecular Diagnosis Sales Market Share by Country in 2024
Figure 53. Europe Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nucleic Acids For Molecular Diagnosis Market Size by Country in 2024
Figure 55. Germany Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nucleic Acids For Molecular Diagnosis Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nucleic Acids For Molecular Diagnosis Market Size by Region in 2024
Figure 68. China Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (K Units)
Figure 79. South America Nucleic Acids For Molecular Diagnosis Sales Market Share by Country in 2024
Figure 80. South America Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (M USD)
Figure 81. South America Nucleic Acids For Molecular Diagnosis Market Size by Country in 2024
Figure 82. Brazil Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nucleic Acids For Molecular Diagnosis Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nucleic Acids For Molecular Diagnosis Market Size by Region in 2024
Figure 92. Saudi Arabia Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nucleic Acids For Molecular Diagnosis Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nucleic Acids For Molecular Diagnosis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nucleic Acids For Molecular Diagnosis Production Market Share by Region (2020-2025)
Figure 103. North America Nucleic Acids For Molecular Diagnosis Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nucleic Acids For Molecular Diagnosis Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nucleic Acids For Molecular Diagnosis Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nucleic Acids For Molecular Diagnosis Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nucleic Acids For Molecular Diagnosis Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nucleic Acids For Molecular Diagnosis Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nucleic Acids For Molecular Diagnosis Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nucleic Acids For Molecular Diagnosis Market Share Forecast by Type (2026-2035)
Figure 111. Global Nucleic Acids For Molecular Diagnosis Sales Forecast by Application (2026-2035)
Figure 112. Global Nucleic Acids For Molecular Diagnosis Market Share Forecast by Application (2026-2035)